WallStreetZenWallStreetZen

NASDAQ: SLRX
Salarius Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SLRX past revenue growth

How has SLRX's revenue growth performed historically?
Company
N/A
Industry
149.51%
Market
17.15%
SLRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SLRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

SLRX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$12.5M
Current Profit Margin
0%

SLRX Return on Equity

Current Company
-198%
Current Industry
-63.5%
Current Market
188%
SLRX's Return on Equity (-198%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SLRX announces earnings.

SLRX Return on Assets

Current Company
-135.2%
Current Industry
2.9%
SLRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SLRX Return on Capital Employed

Current Company
-237.22%
Current Industry
19.5%
SLRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SLRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SLRX$0.00-$12.53M-$12.54M-100.00%N/A
DRMA$0.00-$7.79M-$7.79MN/AN/A
CNSP$0.00-$18.83M-$18.85MN/AN/A
CYTO$0.00-$2.31M-$4.30MN/AN/A
SCNI$0.00N/A-$10.95MN/AN/A
View Top Biotech Stocks

SLRX earnings dates

Next earnings date
May 9, 2024

Salarius Pharmaceuticals Earnings & Revenue FAQ

What were SLRX's earnings last quarter?

On Invalid Date, Salarius Pharmaceuticals (NASDAQ: SLRX) reported Q4 2023 earnings per share (EPS) of $0.00, up 100% year over year. Total Salarius Pharmaceuticals earnings for the quarter were -$881.80 thousand. In the same quarter last year, Salarius Pharmaceuticals's earnings per share (EPS) was -$2.75.

If you're new to stock investing, here's how to buy Salarius Pharmaceuticals stock.

What was SLRX's earnings growth in the past year?

As of Q2 2024, Salarius Pharmaceuticals's earnings has grown year over year. Salarius Pharmaceuticals's earnings in the past year totalled -$12.54 million.

What is SLRX's earnings date?

Salarius Pharmaceuticals's earnings date is Invalid Date. Add SLRX to your watchlist to be reminded of SLRX's next earnings announcement.

What was SLRX's revenue last quarter?

On Invalid Date, Salarius Pharmaceuticals (NASDAQ: SLRX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Salarius Pharmaceuticals's revenue was $0.00.

What was SLRX's revenue growth in the past year?

As of Q2 2024, Salarius Pharmaceuticals's revenue has grown null year over year. Salarius Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.